Alexion on track with FcRn antibody after manufacturing hitchAllbiopro2019-07-28T15:10:13+09:007월 28th, 2019|
Breakthrough Therapy Designation from FDA Received by Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. for LENVIMA® (lenvatinib) plus KEYTRUDA® (pembrolizumab) Combination Treatment as Potential First-Line Treatment of Patients with Advanced UnresectableAllbiopro2019-07-25T23:41:00+09:007월 25th, 2019|
DelMar Pharmaceuticals Enrolls First Patient in the Recently-Approved Adjuvant Setting Arm of Phase 2 Study of VAL-083 for the Treatment of MGMT-Unmethylated Glioblastoma MultiformeAllbiopro2019-07-25T23:40:01+09:007월 25th, 2019|
Varian Reports Results for Third Quarter of Fiscal Year 2019Allbiopro2019-07-25T23:39:04+09:007월 25th, 2019|
Verb Surgical Announces Kurt Azarbarzin as President and CEOAllbiopro2019-07-25T23:38:08+09:007월 25th, 2019|
Aura Biosciences to Present Long-Term Clinical Data for AU-011 at the 37th Annual Scientific Meeting of the American Society of Retina SpecialistsAllbiopro2019-07-25T23:37:14+09:007월 25th, 2019|
Celgene and the Multiple Sclerosis Association of America Bring MS MindShift Initiative and “Brain Bulb” Hot Air Balloon to Festival to Raise Awareness of Multiple Sclerosis and Brain HealthAllbiopro2019-07-25T23:36:17+09:007월 25th, 2019|
REGENXBIO and Neurimmune Announce Collaboration to Develop Vectorized Antibodies for the Treatment of Neurodegenerative DiseasesAllbiopro2019-07-25T23:35:19+09:007월 25th, 2019|
Prodigo Solutions teams up with Amazon Business for eCommerce integrationAllbiopro2019-07-25T23:34:24+09:007월 25th, 2019|
The Importance of 12 Step Principles in Addiction TreatmentAllbiopro2019-07-25T23:33:51+09:007월 25th, 2019|
Neptune Closes SugarLeaf Acquisition, Expanding U.S. Extraction CapabilitiesAllbiopro2019-07-25T23:33:19+09:007월 25th, 2019|
Direct-to-Consumer Hearing Solutions Leader iHEAR® Medical Expands Top-Rated Products to Drugstore Locations NationwideAllbiopro2019-07-25T23:32:49+09:007월 25th, 2019|
Court Order Will Force FDA to Reconsider Braeburn’s Opioid Abuse TreatmentAllbiopro2019-07-25T23:32:18+09:007월 25th, 2019|
FDA’s Sharpless Outlines Agency’s 4 Top Priorities: Tech, Hiring, Modernization and Increased SafetyAllbiopro2019-07-25T23:31:44+09:007월 25th, 2019|
